Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

343 ARTÍCULOS , VIENDO DEL 151 AL 165

Conformation-specific antibodies to target amyloid β oligomers and their application to immunotherapy for Alzheimer's disease

Murakami K.

Biosci Biotechnol Biochem. 2014;78(8):1293-305. doi: 10.1080/09168451.2014.940275.

Pharmacogenomics of Alzheimer's disease: novel therapeutic strategies for drug development

Cacabelos R, Cacabelos P, Torrellas C, Tellado I, Carril JC.

Methods Mol Biol. 2014;1175:323-556. doi: 10.1007/978-1-4939-0956-8_13.

Overview of immunotherapy in Alzheimer's disease (AD) and mechanisms of IVIG neuroprotection in preclinical models of AD

Counts SE, Lahiri DK.

Curr Alzheimer Res. 2014;11(7):623-5. doi: 10.2174/156720501107140815102453.

Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial

Farokhnia M, Shafiee Sabet M, Iranpour N, Gougol A, Yekehtaz H, Alimardani R, Farsad F, Kamalipour M, Akhondzadeh S.

Hum Psychopharmacol. 2014 Jul;29(4):351-9. doi: 10.1002/hup.2412.

SAR studies on carboxylic acid series M(1) selective positive allosteric modulators (PAMs)

Kuduk SD, Beshore DC.

Curr Top Med Chem. 2014;14(15):1738-54. doi: 10.2174/1568026614666140826120224.

Impact of Alzheimer's Disease on Caregiver Questionnaire: internal consistency, convergent validity, and test-retest reliability of a new measure for assessing caregiver burden

Cole JC, Ito D, Chen YJ, Cheng R, Bolognese J, Li-McLeod J.

Health Qual Life Outcomes. 2014 Sep 4;12:114. doi: 10.1186/s12955-014-0114-3.

Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions

Amanatkar HR, Grossberg GT.

Expert Rev Neurother. 2014 Oct;14(10):1119-25. doi: 10.1586/14737175.2014.955852. Epub 2014 Sep 9.

Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease

Kim MH, Kim SH, Yang WM.

Planta Med. 2014 Oct;80(15):1249-58. doi: 10.1055/s-0034-1383038. Epub 2014 Sep 11.

Non-invasive brain stimulation of the right inferior frontal gyrus may improve attention in early Alzheimer's disease: a pilot study

Eliasova I, Anderkova L, Marecek R, Rektorova I.

J Neurol Sci. 2014 Nov 15;346(1-2):318-22. doi: 10.1016/j.jns.2014.08.036. Epub 2014 Aug 29.

Genetic heterogeneity in Alzheimer disease and implications for treatment strategies

Ringman JM, Goate A, Masters CL, Cairns NJ, Danek A, Graff-Radford N, Ghetti B, Morris JC; Dominantly Inherited Alzheimer Network.

Curr Neurol Neurosci Rep. 2014 Nov;14(11):499. doi: 10.1007/s11910-014-0499-8.

Big data: could it ever cure Alzheimer's disease?

Husain M.

Brain. 2014 Oct;137(Pt 10):2623-4. doi: 10.1093/brain/awu245.

Assay suitability for natural product screening: searching for leads to fight Alzheimer's disease

Vasänge M.

Planta Med. 2014 Sep;80(14):1200-9. doi: 10.1055/s-0034-1383063. Epub 2014 Sep 15.

Patents on potential drugs to treat Alzheimer's disease: special emphasis on small peptides

Sundaram P, Nambiar AK, Sundaram RK.

Recent Pat CNS Drug Discov. 2014;9(2):71-5. doi: 10.2174/1574889809666140919123006.

The neurosurgical treatment of Alzheimer's disease: a review

Laxton AW, Stone S, Lozano AM.

Stereotact Funct Neurosurg. 2014;92(5):269-81. doi: 10.1159/000364914. Epub 2014 Sep 18.

Targeting brain α7 nicotinic acetylcholine receptors in Alzheimer's disease: rationale and current status

Vallés AS, Borroni MV, Barrantes FJ.

CNS Drugs. 2014 Nov;28(11):975-87. doi: 10.1007/s40263-014-0201-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias